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Chiral vinylogous sulfonamidopeptides (vs-peptides) were nitrogen atom so as to reduce the acidity of the monomers
and of the oligomers and increase their in vivo bioavailability.synthesized on TentaGel resin employing (S)- and (R)-N-Boc-
vinylogous sulfonyl chlorides 2a–i as building blocks. This synthetic methodology was employed to increase the
diversity in a library of di-N-alkylated vs-dipeptides 26. TheGlycine and two different photocleavable molecules were
used as linkers, and the corresponding cleavage conditions electron-withdrawing capability of the sulfonamido group
pointed to the use of vinylogous sulfonamidopeptides aswere optimized. According to preliminary studies in solution
and on solid phase, three libraries were synthesized with the Michael acceptors. The sodium enolate of dimethyl malonate
was used as nucleophile to obtain N-Boc-ª-lactams 35 in“split-mix synthesis” method. Taking advantage of the acidic
character of the sulfonamides (RSO2–NHR: pKa = 10–11), moderate yields and good diastereoselectivity.
mild conditions were developed to alkylate the sulfonamide
Introduction interesting candidates in the development of protease in-
hibitors and new drugs. [8] The synthesis in solution of bothThe current goal in drug discovery is to rapidly synthesize
â-sulfonamidopeptides[9] and chiral vinylogous sulfonami-as many structurally diverse substances as possible, so that,
dopeptides (vs-peptides) [10] [11] has been developed by ourin combination with high-throughput screening, the search
research group starting from natural Æ-amino acids by anfor new lead structures and their optimization can be accel-
iterative process based on a straightforward protection-de-erated. A response to this need is provided by combinatorial
protection-coupling chemistry (Figure 1).chemistry. [1] The vast majority of the presently available
combinatorial approaches makes use of SPS (Solid Phase
Figure 1. Vinylogous sulfonamido peptides (vs-peptides)Synthesis), which was first developed and optimized for
peptides. [2] However, the poor bioavailability and rapid en-
zymatic degradation of peptides in vivo have generally lim-
ited their therapeutic application. One approach to over-
come this obstacle has been the development of non-natural
biopolymer scaffolds (carbamates, peptoids, ureas, sulfona-
mides, â-peptides, â-peptoids, etc.) [3] which may show im-
proved pharmacological properties relative to peptides. As a Some methods for the SPS of sulfonamides have ap-
peared in the literature; [7e] [7g] [12] our main effort aimed atconsequence, research on the solid-phase synthesis of non-
natural oligomers and small organic molecules has received the development of SPS of vs-peptides[13] and at the appli-
cation of these techniques to combinatorial chemistry. Inincreasing attention. [3] [4]
At present, several approaches are available for the prep- this paper, the successful synthesis of three different vs-pep-
tide libraries is described. Moreover, post-synthetic func-aration of peptide isosters[5] and their synthesis on solid
support. [6] In particular, sulfonamides[7] should show en- tionalization of vs-peptides was achieved by generating N-
alkylated oligomers by selective alkylation of the sulfonam-hanced metabolic stability and structural similarity to the
tetrahedral transition state involved in the enzymatic amide ide group,[14] and by Michael addition of stabilized enolates
to the electrophilic conjugated double bond.[15]bond hydrolysis, [7a] [7b] [7c] thus making sulfonamidopeptides
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Results and Discussion Scheme 2. Solid-phase synthesis of vs-peptides using TentaGel-
NH2 resin and photocleavable linkers
Solid Phase Synthesis of vs-Peptides
Two different types of TentaGel resins[16] were employed
in the work here outlined: TentaGel-OH[16c] and TentaGel-
NH2[16c] (Scheme 1 and Scheme 2). Boc-glycine was at-
tached as linker to TentaGel-OH resin affording func-
tionalized resin 1, while photocleavable linkers[17] were em-
ployed with TentaGel-NH2 resin to give functionalized re-
sins 8 [Boc-linker-A-NH-TentaGel (linker A 5 4-amino-
methyl-3-nitrobenzoic acid)] and 9 [Fmoc-linker-B-NH-
Tentagel (linker-B 5 aminoethyl Photolinker Nova-
Syn)[17b]].
Scheme 1. Solid-phase synthesis of vs-peptides using TentaGel-OH
resin and glycine linker
a: i. TFA 25% in DCM; ii. DIPEA 5% in DCM; b: Piperidine 20%
in DMF; c: 2a2i, NMM, DMAP, DCM; d: HCl, EtOAc (to be
used when O-TBDPS protective group is present in the vs-peptide
sequence, see 2h and 2i).
Our SPS of vs-peptides made use of N-Boc vinylogous
amino sulfonyl chlorides[11a] [11b] [11c] 2a2i and followed a
Boc-protection-adapted strategy. Contrary to the synthesis
in solution, [11a] [11b] [11c] SPS allows the use of TFA for Boc
deprotection, as the ammonium trifluoroacetate salts can
be neutralized to free amines, and the risk of obtaining tri-
fluoroacetamides during the subsequent coupling step is
thus avoided. The free amines were coupled with N-Boc
vinylogous amino sulfonyl chlorides[11a] [11b] [11c] 2a2i to
give vinylogous sulfonamides 3, 12, 13. According to the
protocol for the synthesis in solution, [11a] [11b] [11c] we used
1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) and 4-dimeth-
ylaminopyridine (DMAP) to run the coupling reactions on
solid support. [13] More recent experiments have demon-
strated that DBU leads to partial decomposition of the sul-
fonyl chlorides because of the long time required by the
coupling. Replacement of DBU by 2,6-lutidine, N-methyl-
imidazole or triethylamine was not successful either. By em-
ploying N-methylmorpholine (NMM), in the presence of a
substoichiometric amount of DMAP, a reasonable stabilitya: Boc-Gly-OH, DMAP, DIPC, DCM; b: i. TFA 25% in DCM; ii.
DIPEA 5% in DCM; c: 2a2g, NMM, DMAP, DCM; d: TEA, of the sulfonyl chlorides was achieved, thus allowing a cle-
MeOH; e: NH3, MeOH; f: NaOH, MeOH; g: CH2N2. aner coupling to the solid-phase-supported amines in a
minor number of cycles. The optimized coupling reactions
were performed by treating the resin-bound amines with 0.5At the beginning of the synthesis, the tert-butoxycarbonyl
(Boc) group was removed from resins 1 and 8 by treating equivalents of DMAP, 1.0 equivalent of NMM and 2.0
equivalents of N-Boc vinylogous amino sulfonyl chloride inwith 25% trifluoroacetic acid (TFA) in dichloromethane
(DCM), and the resulting ammonium salts were neutralized DCM. The coupling reactions were monitored with bromo-
phenol blue (BPB), [18] while the traditional Kaiser ninhyd-by washing with 5% diisopropylethylamine (DIPEA) in
DCM. In the case of resin 9, the 9-fluorenylmethoxycar- rin test [19] proved less suitable. Using this protocol, we syn-
thesized vs-dipeptides 4, 14 on solid support in moderatebonyl (Fmoc) group was removed with a 20% solution of
piperidine in N,N-dimethylformamide (DMF) to give free to good yields and excellent purity, as determined by sub-
sequent cleavage from the resin (see below).amine 11.
Eur. J. Org. Chem. 1998, 2437224492438
Synthesis of Combinatorial Libraries of Vinylogous Sulfonamidopeptides (vs-Peptides) FULL PAPER
vs-Peptides were cleaved from the solid support (Tent- allowed the selective N-alkylation of the more acidic sulfon-
amide group (RSO22NHR: pKa 5 10211 vs. Boc2NH:aGel-OH resin, glycine linker) by direct ester methanolysis
(10% TEA in MeOH) to give the desired glycine methyl pKa 5 15216) (Scheme 4).
ester derivatives 5, 7 in 20260% yield after chromatogra-
Scheme 4. N-Alkylation of vs-peptides in solution and on solidphy. Alternatively, the cleavage of the products from the phase
solid support (TentaGel-OH resin, glycine linker) was per-
formed by saponification of the Gly-O-TentaGel ester
(NaOH/MeOH) and subsequent esterification (CH2N2) of
the carboxylic acid to afford the corresponding glycine
methyl ester derivatives 5 in good yields (60%). Direct ester
ammonolysis (saturated NH3 in MeOH) gave the glycine
carboxyamide derivatives 6 in poor yields (15220%). The
protected vinylogous sulfonyl derivatives of serine
[2vsSer(TBDPS)2] and tyrosine [2vsTyr(TBDPS)2] could
be inserted into the vs-peptide sequence only when Tent-
aGel-NH2 and photocleavable linkers were employed (vide
infra). In fact, the basic conditions (1  Bu4NF in THF)
needed for O-TBDPS deprotection also cleaved the Gly-O-
TentaGel ester, precluding the use of this kind of support
and linker.
Resin-bound vs-peptides 12, 13, 14 were cleaved from the
solid support [TentaGel-NH2 resin, photocleavable linkers
A and B] by swelling the resin in MeOH and irradiating for
124 days at 354 nm, to give 15 and 16 in 30286% yields.
For both photocleavable linkers we observed a peak in the
release of the products during the first 10220 hours of
a: R2X, Cs2CO3, THF; b: R2X, Cs2CO3, DMF; c: hí, MeOH.exposure to the light. After that time, the release continued
at a much slower rate. From these studies, linker-B was con-
By treating N-Boc protected vs-peptides with Cs2CO3firmed to be the best of the two,[17a] affording vs-peptides
and various alkylating agents [methyl iodide (MeI), ethyl15 and 16 in higher yields (77286%) and no by-products
iodide (EtI), benzyl bromide (BnBr), 2-(bromomethyl)-(Scheme 3).
naphthalene (NaphtCH2Br), allyl bromide (AllBr)] in THF,
N-alkylsulfonamides 18, 20, 22 were obtained in moderateScheme 3. Photocleavage of vs-peptides from TentaGel-NH2 resin
to good yields (402100%). The same reaction was success-
fully transferred to the solid phase, where it was possible to
drive the reaction to completion by repeating the alkylation
cycles. In SPS, the use of DMF as solvent, where Cs2CO3
is soluble, proved favourable by avoiding the formation of
a three-phase system, accelerating the reactions and im-
proving the yields. A representative case is shown in Scheme
4, where compound 23 was obtained as a single product in
high purity after photocleavage (50% yield). The N-alky-
lation reactions could be performed only when TentaGel-
NH2 and photocleavable linkers were employed. The basic
N-Alkylation of vs-Peptides in Solution and on Solid Phase conditions (Cs2CO3, DMF) needed for sulfonamide alky-
lation also cleaved the Gly-O-TentaGel ester, precluding theN-Alkylation of the sulfonamide groups seems an effec-
use of this kind of support and linker.tive way to reduce the acidity of vs-peptides and to increase
their bioavailability. Several methods are known for N-alky-
lation of amides and sulfonamides, both in solution and on Synthesis of Combinatorial Libraries of vs-Peptides
solid phase. [14] Treatment of vs-peptides with diethyl azod-
icarboxylate (DEAD), triphenylphosphane and alcohols led Once the synthetic strategies had been established, we set
out to synthesize three different libraries of sulfonopeptidesto no alkylated product, although the Mitsunobu reaction
is known to alkylate acidic compounds like phenols and by the “split-mix synthesis” method, which is the most
common approach for the synthesis of compound mix-also sulfonamides. [14a] [14b] [14c] [14d] [14e] The known methods
for amide alkylation in peptide synthesis were not appli- tures.[20]
For the synthesis of a library of di-N-alkylated vs-dipep-cable to Boc-protected vs-peptides, since the use of strong
bases like NaH or tBuOK led to both BocNH and tides, TentaGel-NH2 resin and the photocleavable linker-B
were employed, together with seven sulfonyl chloridesRSO2NHR alkylation. The use of a milder base (Cs2CO3)
Eur. J. Org. Chem. 1998, 243722449 2439
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2a2g, and three alkylating agents [MeI, PhCH2Br (BnBr), pools A [21 N-monoalkylated vs-dipeptides where the last
vs-amino acid added is (S)-vsAla] and V [21 N-monoalkyl-CH25CHCH2Br (AllBr)], so as to obtain in principle [7 3
3 3 7 3 3] 5 441 di-N-alkylated vs-dipeptides (Scheme 5, ated vs-dipeptides where the last vs-amino acid added is
(S)-vsVal]; the pool L-F-P (63 N-monoalkylated vs-dipep-6). The general formula of the library is Boc-vsAA2-N(R2)-
vsAA1-N(R1)-linker-B-resin (26), apart from the special tides), obtained mixing pools L [21 N-monoalkylated vs-
dipeptides where the last vs-amino acid added is (S)-vsLeu],case when vsAA1 5 (L)- or (D)-vsPro (a secondary amine)
and the formula then becomes Boc-vsAA2-vsPro-N(R1)- F [21 N-monoalkylated vs-dipeptides where the last vs-am-
ino acid added is (S)-vsPhe] and P [21 N-monoalkylated vs-linker-B-resin, with a reduction of the total number of com-
pounds from 441 to 357. dipeptides where the last vs-amino acid added is (S)-vsPro];
the pool f-p (42 N-monoalkylated vs-dipeptides), obtained
Scheme 5. Synthesis of the library of 357 di-N-alkylated vs-dipepti- mixing pools f [21 N-monoalkylated vs-dipeptides wheredes
the last vs-amino acid added is (R)-vsPhe] and p [21 N-
monoalkylated vs-dipeptides where the last vs-amino acid
added is (R)-vsPro]. Each of these three pools was split into
three subpools for the fourth library step. Each subpool A-
V, L-F-P, and f-p, suspended in DMF, was treated with
Cs2CO3 and the alkylating agent (AllBr, MeI, and BnBr)
to give 26. The mixtures were shaken for 6 hours and the
alkylating cycle was repeated 4 times. In this way, 9 sub-
pools were generated, each containing a minimum of 42
and a maximum of 63 di-N-alkylated vs-dipeptides, for
which the last alkylating agent used is known (Scheme 6).
In this way, the number of compounds present in each
subpool was mantained relatively low (42263), so as to
make library screening and deconvolution easier. The com-
pounds were released from the resin by photolysis, and the
biological activity of the subpools [general formula Boc-
vsAA2-N(R2)-vsAA1-NH(R1)] is presently under evalua-
tion, using “recursive deconvolution”[22] in order to identify
the structure of “active” compounds in the pools.
The second library was synthesized on TentaGel-NH2 re-
sin, employing the photocleavable linker-B and nine sul-
fonyl chlorides 2a2i, to give a total of [9 3 9 3 9] 5 729 vs-a: R1X, Cs2CO3, DMF (R1 5 Me, Bn, All); b: i. TFA 25% in
DCM; ii. DIPEA 5% in DCM; c: 2a2g, NMM, DMAP, DCM; d: tripeptides. Functionalized vs-amino acids[11b] derived from
R2X, Cs2CO3, DMF (R2 5 Me, Bn, All). serine [vrSer(TBDPS)] and tyrosine [vrTyr(TBDPS)] were
introduced in this library. As the growing vs-peptide chainThe resin Fmoc-linker-B-NH-TentaGel (9) was split into
7 pools and each pool was treated with 20% piperidine in contained a tert-butyl diphenylsilyloxy (TBDPS-O) group
[the hydroxy protecting group in 2vsSer(TBDPS)2 andDMF. In the first library step, each pool suspended in
DCM was treated with DMAP, NMM, and sulfonyl chlo- 2vsTyr(TBDPS)2], the Boc cleavage had to be performed
with a saturated HCl solution in ethyl acetate to prevent O-rides Boc-vsAA1-Cl (2a2g) to give 13. The mixtures were
shaken for 18 hours, and the coupling cycle was repeated 3 TBDPS deprotection.[23] In the last step, the TBDPS group
was removed treating the resin with Bu4NF in THF, accord-times to ensure complete conversion. At the end of each
cycle the resin was checked with the BPB test. [18] [21] The 7 ing to the protocol successfully employed in solution for
serine and tyrosine. [11b] The synthesis of this library [gen-pools were mixed together in the same flask with DCM
and split into 3 pools. In the second library step, each pool eral formula Boc-vsAA3-vsAA2-vsAA1-linker-B-NH-Tent-
aGel (29)] is outlined in Scheme 7.suspended in DMF was treated with Cs2CO3 and the alkyl-
ating agent (AllBr, MeI, and BnBr) to give 24. The mixtures In the synthesis of the third library (first in chronological
order) five sulfonyl chlorides 2a2d, 2f, TentaGel-NH2 resinwere shaken for 6 hours, and the alkylating cycle was re-
peated 4 times to ensure complete conversion. The 3 pools and photocleavable linker-A were used, to give a total of [5
3 5 3 5 3 5] 5 625 vs-tetrapeptides [general formula Boc-were mixed together in the same flask, the resin was treated
with 25% TFA in DCM and then split into 7 pools. In the vsAA4-vsAA3-vsAA2-vsAA1-linker-A-NH-TentaGel (33)]
(Scheme 8). The synthesis of this library is analogous to thethird library step, each pool suspended in DCM was treated
with NMM, DMAP, and sulfonyl chlorides Boc-vsAA2-Cl one described above in Scheme 7, the main difference being
the use of DBU instead of NMM. The number of coupling(2a2g) to give 25. The mixtures were shaken for 16 hours
and the coupling cycle was repeated 3 times. At the end of cycles necessary in each step of the third library (4232
cycles) reveals a sharp increase in coupling efficiency foreach cycle the resin was checked with the BPB test. [18] [21]
The 7 pools were mixed to form three new pools: the pool the two libraries outlined above (223 cycles). A possible
explanation is that DBU is not only aggressive toward sul-A-V (42 N-monoalkylated vs-dipeptides), obtained mixing
Eur. J. Org. Chem. 1998, 2437224492440
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Scheme 6. Library scheme for the 357 di-N-alkylated vs-dipeptides
O 5 TentaGel-NH-linker-B; A 5 (S)-vsAla; V 5 (S)-vsVal; L 5 (S)-vsLeu; F 5 (S)-vsPhe; P 5 (S)-vsPro; f 5 (R)-vsPhe; p 5 (R)-vsPro;
x 5 vsAA; R 5 Me, Bn, All; X1 5 (S)-vsAla or (S)-vsVal; X2 5 (S)-vsLeu or (S)-vsPhe or (S)-vsPro; X3 5 (R)-vsPhe or (R)-vsPro.
Michael Addition Reactions to vs-Peptidesfonyl chlorides but can also interfere with the BPB
test, [18] [21] giving rise to false positives. The new optimized
The sulfonamide group [2SO2NR2; R 5 Me; R, R 5coupling conditions (NMM, DMAP) allow to perform SPS
2(CH2)52] confers a low electrophilic character to the con-of vs-peptides in high yield and purity with a reasonable
number of coupling cycles and do not interfere with the Scheme 8. Synthesis of the library of 625 vs-tetrapeptides
BPB test, which can be used as a reliable method to moni-
tor the conversion at each coupling cycle. [18] [21]
Scheme 7. Synthesis of the library of 729 functionalized vs-tripep-
tides
a: i. TFA 25% in DCM; ii. TEA 10% in DCM; b: 2a2d, 2f, DBU,a: i. HCl, EtOAc; ii. DIPEA 5% in DCM; b: 2a2i, NMM, DMAP,
DCM; c: TBAF in THF. DMAP, DCM.
Eur. J. Org. Chem. 1998, 243722449 2441
C. Gennari et al.FULL PAPER
jugated double bond of vs-peptides, and the corresponding cleophilic epoxidation of ª-alkoxy-Æ,â-unsaturated sul-
fones. [25b] [25c]Michael addition reactions are sluggish. Diastereoselective
Michael addition reactions to optically active trifluorome-
Figure 2. Transition-state model for the Michael addition reactionthylated Æ,â-unsaturated sulfonamides of lithium or sodium to vs-peptides
enolates have recently been reported.[15] The strong elec-
tron-withdrawing capability of the trifluoromethyl group is
responsible for the high reactivity of these substrates. [15]
The Michael addition reaction of various stabilized enol-
ates (derived from 1,3-dicarbonyl compounds) was tested
on vs-peptides 34, and satisfactory results were obtained
with dimethyl malonate and NaH in THF at 60°C. The The addition reaction of the sodium enolate of dimethyl
outcome of such reactions is interesting, since no simple malonate to (S)-Boc-vs-Val-NMe2 [34; R 5 iPr; R1 5 Me]
addition products were observed: after the addition of the gave a single diastereoisomer [35; R 5 iPr; R1 5 Me; R2 5
carbon nucleophile to the double bond, attack of the carba- CO2CH3] in good yield (56%). Addition of sodium di-
mate nitrogen atom onto the methyl ester takes place and methyl malonate to other substrates (S)-Boc-vs-AA-NMe2
ª-lactam products 35 are isolated in poor to moderate yields [34; R 5 Me or iBu; R1 5 Me] gave poorer results
(20256%) (Scheme 9). The leaving group on the ester is of (20240%). The use of different nucleophiles, such as so-
particular importance: the use of diethyl malonate did not dium dimethyl methylmalonate, or sodium methyl cyano-
lead to the cyclic product, and the Michael addition prod- acetate, also gave low yields of pyrrolidinones.
uct was not observed either, since the first step is probably
reversible. The addition reactions were initially studied on
the piperidine derivative of (S)-Boc-vs-Ala [34; R 5 Me; Conclusions
R1, R1 5 2(CH2)52]. Two new stereocentres are formed
A feasible route to the solid-phase synthesis of vinylog-during the addition-ring closure reaction, leading to four
ous sulfonamidopeptides (vs-peptides) was developed onpossible diastereoisomers.
Tentagel resin employing (S) and (R)-N-Boc-vinylogous sul-
fonyl chlorides 2a2i. Glycine and two different photocleav-
Scheme 9. Michael addition reactions to vs-peptides able molecules (A and B, Scheme 2) were used to link the
substrates to the solid support. The optimal coupling con-
ditions (NMM, DMAP) allowed chain elongation in good
yields. Cleavage of vs-peptides from the resin was achieved
either by transesterification (glycine linker) or by photolysis
(A and B linkers). In the latter case, linker-B proved to be
the best choice. Vs-peptides were selectively N-alkylated at
the sulfonamide group using Cs2CO3 as a base. Synthesis
of three different vs-peptide libraries was achieved whose
potential biological activity is currently under evaluation.
vs-Peptides were also subjected to the Michael addition re-
action, affording N-Boc-ª-lactams in moderate yields and
good diastereoselectivity.
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with the NOE data. Experimental Section
According to the major diastereoisomer formed, the di-
General: Nuclear magnetic resonance spectra were recorded withrection of attack of the nucleophile at the Æ,â-unsaturated
Bruker AC-200, AC-300, AC-500, Varian XL-200 and XL-400 in-
sulfonamide possessing a stereogenic centre in the ª posi- struments. 2 Optical rotations were determined using a Perkin
tion, is probably as shown in Figure 2. This transition-state Elmer 141 polarimeter. 2 IR spectra were recorded with a Perkin
model is in accordance with that proposed by Yamamoto Elmer 457 and an FT-IR Varian spectrometer. 2 All products were
in the context of conjugate addition of cuprates to ª-alkoxy- purified by flash chromatography using 2302400 mesh silica gel
(Merck). 2 TLC analyses were performed with 0.25 mm 60 F254Æ,â-unsaturated esters, [25a] [25c] and by Jackson for the nu-
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silica plates (Merck). 2 All solvents trahydrofuran (THF), Et2O, with DCM (5 3 5 ml), neutralized with 5% DIPEA in DCM (3 3
5 ml) and washed with DCM (5 3 5 ml). To this resin in DCM (5benzene, toluene, dichloromethane (DCM), N,N-dimethylformam-
ide (DMF), MeOH] for solid-phase synthesis were analytical grade ml) were added (S)-Boc-vsAla-Cl (2a, 67.3 mg, 0.250 mmol),
NMM (12.7 mg, 0.125 mmol) and DMAP (7.6 mg, 0.0625 mmol).or HPLC grade. THF for Michael addition reactions and vs-pep-
tide N-alkylations was distilled from sodium under nitrogen, diiso- The mixture was shaken for 24 h and then washed with DCM (3
3 5 ml), MeOH (3 3 5 ml) and DCM (5 3 5 ml). The couplingpropylethylamine (DIPEA) and triethylamine (TEA) were distilled
from CaH2 under nitrogen. All solid-phase reactions were carried cycle was repeated twice, checking at the end of each cycle with the
BPB test. [18] [21] The resin was suspended in DCM (5 ml) and aceticout with a wrist shaker (Multi-wrist Shaker Lab-line). Organic ex-
tracts were dried with Na2SO4. anhydride (0.50 ml) was added. The mixture was shaken for 12 h
and then washed with DCM (5 3 5 ml), DMF (5 3 5 ml) andSolid Phase Synthesis: TentaGel-OH Resin and Glycine Linker
DCM (5 3 5 ml).
Boc-Gly-OTentaGel (1): Resin TentaGel-OH (3 g, 0.78 mmol;
(S)-Boc-vsAla-linker-B-NH-TentaGel (13, vsAA1 5 vsAla):Rapp Polymere, Tübingen, Germany) in DCM (30 ml) was treated
Fmoc-aminoethyl-Photolinker NovaSyn TG resin (Fmoc-linkerB-with Boc-Gly-OH (410 mg, 2.34 mmol), diisopropylcarbodiimide
NH-TentaGel, Novabiochem)[17b] (9, 600 mg, 0.138 mmol) was(DIC) (295.3 mg, 0.367 ml, 2.34 mmol) and DMAP (9.5 mg, 0.078
treated with 20% piperidine in DMF (2 3 6 ml); the resin wasmmol). The mixture was shaken for 24 h and then washed with
washed with DMF (3 3 6 ml) and DCM (5 3 6 ml). To this resinDCM (5 3 30 ml). The coupling cycle was repeated 3 times and at
in DCM (6 ml) were added (S)-Boc-vsAla-Cl (2a, 74.4 mg, 0.276the end of the third cycle the resin was washed with DCM (5 3 30
mmol), NMM (14 mg, 0.138 mmol) and DMAP (8.4 mg, 0.069ml), DMF (3 3 30 ml), MeOH (3 3 30 ml) and DCM (3 3 30 ml).
mmol). The mixture was shaken for 24 h and then washed with
(S)-Boc-vsAla-Gly-OTentaGel (3, vsAA1 5 vsAla): The resin DCM (3 3 6 ml), MeOH (3 3 6 ml) and DCM (5 3 6 ml). The
Boc-Gly-OTentaGel (1, 500 mg, 0.13 mmol) was treated with 25% coupling cycle was repeated twice, checking at the end of each cycle
trifluoroacetic acid (TFA) solution in DCM (3 3 5 ml), washed with the BPB test. [18] [21] The resin was suspended in DCM (6 ml)
with DCM (5 3 5 ml), neutralized with 5% DIPEA in DCM (3 3 and acetic anhydride (0.60 ml) was added. The mixture was shaken
5 ml) and washed again with DCM (5 3 5 ml). To this resin in for 12 h and then washed with DCM (5 3 6 ml), DMF (5 3 6 ml)
DCM (5 ml) were added (S)-Boc-vsAla-Cl (2a, 70 mg, 0.26 mmol), and DCM (5 3 6 ml).
N-methylmorpholine (NMM) (13.1 mg, 0.13 mmol), and DMAP
(S)-Boc-vsPhe-(S)-vsAla-linker-B-NH-TentaGel (14, vsAA1 5(8 mg, 0.065 mmol). The mixture was shaken for 24 h and then
vsAla, vsAA2 5 vsPhe): The resin (S)-Boc-vsAla-linker-B-NH-washed with DCM (3 3 5 ml), MeOH (3 3 5 ml) and DCM (5 3
TentaGel (13, vsAA1 5 vsAla) (600 mg, 0.138 mmol) was treated5 ml). The coupling cycle was repeated 3 times, checking at the end
with 25% TFA in DCM (3 3 6 ml); the resin was washed with
of each cycle with the bromophenol blue (BPB) test. [18] [21] The resin
DCM (5 3 6 ml), neutralized with 5% DIPEA in DCM (3 3 6 ml)
was suspended in DCM (5 ml) and acetic anhydride (0.50 ml) was
and washed with DCM (5 3 6 ml). To this resin in DCM (6 ml)
added. The mixture was shaken for 12 h and then washed with
were added (S)-Boc-vsPhe-Cl (2d, 95.4 mg, 0.276 mmol), NMM
DCM (5 3 5 ml), DMF (5 3 5 ml) and DCM (5 3 5 ml).
(14 mg, 0.138 mmol) and DMAP (8.4 mg, 0.069 mmol). The mix-
(S)-Boc-vsPhe-(S)-vsAla-Gly-OTentagel (4, vsAA1 5 vsAla, ture was shaken for 24 h and then washed with DCM (3 3 6 ml),
vsAA2 5 vsPhe): The resin (S)-Boc-vsAla-Gly-OTentaGel (3, MeOH (3 3 6 ml) and DCM (5 3 6 ml). The coupling cycle was
vsAA1 5 vsAla) (500 mg, 0.13 mmol) was treated with 25% TFA repeated twice, checking at the end of each cycle with the BPB
solution in DCM (3 3 5 ml), washed with DCM (5 3 5 ml), neu- test. [18] [21] The resin was suspended in DCM (6 ml) and acetic anhy-
tralized with 5% DIPEA in DCM (3 3 5 ml) and washed again dride (0.60 ml) was added. The mixture was shaken for 12 h and
with DCM (5 3 5 ml). To this resin in DCM (5 ml) were added then washed with DCM (5 3 6 ml), DMF (5 3 6 ml) and DCM
(S)-Boc-vsPhe-Cl (2d, 90 mg, 0.26 mmol), NMM (13.1 mg, 0.13 (5 3 6 ml).
mmol) and DMAP (8 mg, 0.065 mmol). The mixture was shaken
Cleavage of Sulfonopeptides from TentaGel-OH Resin
for 24 h and then washed with DCM (3 3 5 ml), MeOH (3 3 5
(S)-Boc-vsAla-Gly-NH2 (6, vsAA1 5 vsAla): The resin (S)-Boc-ml) and DCM (5 3 5 ml). The coupling cycle was repeated 3 times,
vsAla-Gly-OTentagel (3, vsAA1 5 vsAla) (500 mg, 0.13 mmol) waschecking at the end of each cycle with the BPB test. [18] [21] The resin
treated with 5 ml of a NH3 saturated MeOH solution. The mixturewas suspended in DCM (5 ml) and acetic anhydride (0.50 ml) was
was shaken for 20 h and then the organic phase was filtered off andadded. The mixture was shaken for 12 h and then washed with
evaporated at reduced pressure. The crude product was purified byDCM (5 3 5 ml), DMF (5 3 5 ml), DCM (5 3 5 ml).
flash chromatography (ethyl acetate) to give the desired product in
TentaGel-NH2 Resin and Photocleavable Linker 20% yield. 2 1H NMR (200 MHz, CDCl3): ä 5 1.3 (3 H, d,
Boc-linker-A-NH-TentaGel (8): Resin TentaGel-NH2 (1 g, 0.25 CH3CH, J 5 6.3 Hz); 1.43 (9 H, s, [CH3]3C); 3.6 (2 H, s, CH2CO);
mmol; Rapp Polymere, Tübingen, Germany) in DMF (10 ml) was 4.30 (1 H, m, CHN); 6.3 (3 H, broad, NH 1 CONH2); 6.39 (1 H,
treated with DIC (69.4 mg, 0.55 mmol), HOBt (186 mg, 1.375 dd, CH5CH, J 5 14.7 Hz, J 5 1.5 Hz); 6.67 (1 H, dd, CH5CH,
mmol) and after 10 min Boc-4-aminomethyl-3-nitrobenzoic acid J 5 14.7 Hz, J 5 5.1 Hz).
(Boc-linker-A; 148 mg, 0.5 mmol). The mixture was shaken for 12 (S)-Boc-vsVal-(S)-vsPro-Gly-OMe (7, vsAA1 5 vsPro, vsAA2 5h and then washed with DMF (3 3 5 ml), MeOH (3 3 10 ml) and vsVal): The resin (S)-Boc-vsVal-(S)-vsPro-Gly-OTentagel (4,
DCM (5 3 10 ml). The coupling cycle was repeated 6 times, check- vsAA1 5 vsPro, vsAA2 5 vsVal) (500 mg, 0.13 mmol) was washeding at the end of each cycle with the BPB test. [18] [21] The resin was with MeOH (5 3 5 ml) and then treated with 10% TEA in MeOH
suspended in DCM (10 ml) and acetic anhydride (1.00 ml) was (8 ml). The mixture was shaken for 24 h and washed with MeOH
added. The mixture was shaken for 12 h and then washed with (5 3 5 ml) at the end of each cycle. The organic fractions were
DCM (5 3 10 ml), DMF (5 3 10 ml) and DCM (5 3 10 ml). collected and evaporated. The crude product was purified by flash
chromatography (n-hexane/ethyl acetate, 6:4) to give the desired(S)-Boc-vsAla-linker-A-NH-TentaGel (12, vsAA1 5 vsAla): The
resin Boc-linker-A-NH-Tentagel (8, 500 mg, 0.125 mmol) was product in 20% yield. The spectra are identical to those reported
for the compound synthesized in solution.[11b]treated with 25% TFA in DCM (3 3 5 ml); the resin was washed
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(S)-Boc-vsAla-Gly-OMe (5, vsAA1 5 vs Ala): According to the (S)-Boc-vsVal-N(Me)Bn (18, R 5 iPr, R1 5 Bn, R2 5 Me):
According to the above procedure, the desired product was ob-above procedure the desired product was obtained in 52% yield
after purification by flash chromatography (n-hexane/ethyl acetate, tained in 100% yield after purification by flash chromatography (n-
hexane/ethyl acetate, 8:2). 2 1H NMR (200 MHz, CDCl3): ä 56:4). The spectra are identical to those reported for the compound
synthesized in solution.[11b] 0.95 (3 H, d, CH3CHCH3, J 5 6.8 Hz); 0.99 (3 H, d, CH3CHCH3,
J 5 6.8 Hz); 1.47 (9 H, s, [CH3]3C); 1.88 [1 H, m, (CH3)2CH); 2.69(S)-Boc-vsAla-Gly-OMe (5, vsAA1 5 vs Ala): The resin (S)-Boc- (3 H, s, CH3N); 4.23 (1 H, m, NHCH); 4.25 (2 H, s, NCH2Ph);vsAla-Gly-OTentagel (3, vsAA1 5 vs Ala) (310 mg, 0.081 mmol) 4.58 (1 H, d, NH, J 5 6.4 Hz); 6.27 (1 H, dd, CH5CHSO2, J 5in MeOH (4 ml) was treated with 4 ml of a 0.1  NaOH solution
1.2 Hz, J 5 15.1 Hz); 6.68 (1 H, dd, CH5CHSO2, J 5 5.5 Hz,(0.4 mmol). The mixture was shaken for 20 h and then the solvent
J 5 15.1 Hz); 7.35 (5 H, m, ArH). 2 13C NMR (CDCl3): ä 5was filtered off and evaporated at reduced pressure. The crude
18.01 (CH3); 18.77 (CH3); 28.22 ([CH3]3); 31.81 (CH); 34.03product was then dissolved in a solution at pH 5 3 (HCl, H2O), (CH3N); 53.74 (CH2); 56.46 (CH); 125.70 (CH5); 127.87 (CH5the aqueous phase was exctracted with DCM, and the combined
); 128.28 (CH5); 128.59 (CH5); 144.96 (CH5). 2 C19H30N2O4Sorganic extracts were dried and concentrated. The crude product
(382.5): calcd. C 59.66, H 7.91, N 7.32, O 16.73, S 8.38; found Cwas treated with CH2N2 in Et2O; after 1 h, the solvent was removed 59.59, H 7.98, N 7.27.at reduced pressure and the product was purified by flash chroma-
tography (n-hexane/ethyl acetate, 1:1) giving the pure methyl ester (S)-Boc-vsAla-N(Me)-Gly-OMe (18, R 5 Me, R1 5 CH2CO2-
in 60% yield. The spectra are identical to those reported for the CH3, R2 5 Me): According to the above procedure, the desired
compound synthesized in solution.[11b] product was obtained in 80% yield after purification by flash chro-
matography (n-hexane/ethyl acetate, 6:4). 2 1H NMR (200 MHz,Cleavage of Sulfonopeptides from TentaGel-NH2 Resin
CDCl3): ä 5 1.3 (3 H, d, CH3CH, J 5 6.7 Hz); 1.47 (9 H, s,(S)-Boc-vsAla-NH2 (15, R 5 Me): A suspension of (S)-Boc- [CH3]3C); 2.89 (3 H, s, NCH3); 3.76 (3 H, s, OCH3); 4.04 (2 H, s,vsAla-linker-A-NH-TentaGel (12, vsAA1 5 vsAla) (200 mg, 0.05 CH2); 4.5 (2 H, broad, NHCH 1 NHCH); 6.3 (1 H, dd, CH5mmol) in dry MeOH (5 ml), in a Pyrex reactor, was irradiated for
CHSO2, J 5 1.4 Hz, J 5 15.1 Hz); 6.7 (1 H, dd, CH5CHSO2, J 531 h at 354 nm with a 125-W Hg lamp, under shaking. The solvent
4.6 Hz, J 5 15.1 Hz). 2 C13H24N2O6S (336.4): calcd. C 46.42, Hwas collected and the resin was washed with MeOH (5 3 2 ml).
7.19, N 8.33, O 28.54, S 9.53; found C 46.37, H 7.26, N 8.27.
The combined organic fractions were concentrated at reduced
pressure. The residue was purified by flash chromatography (n-hex- (S)-Boc-vsAla-N(Me)-Gly-NH2 (18, R 5 Me, R1 5 CH2CO-
ane/ethyl acetate, 6:4) to give the desired product in 30% yield. The NH2, R2 5 Me): According to the above procedure, the desired
spectra are identical to those reported for the compound synthe- product was obtained in 60% yield after purification by flash chro-
sized in solution.[11b] matography (n-hexane/ethyl acetate, 9:1). 2 1H NMR (200 MHz,
CDCl3): ä 5 1.3 (3 H, d, CH3CH, J 5 7.7 Hz); 1.47 (9 H, s,(S)-Boc-vsAla-NH2 (15, R 5 Me): A suspension of (S)-Boc-
[CH3]3C); 2.7 (3 H, s, CH3N); 3.7 (2 H, s, CH2); 4.4 (1 H, m,vsAla-linker-B-NH-TentaGel (13, vsAA1 5 vsAla) (109 mg, 0.025
CH3CH); 6.3 (1 H, broad, NHCH); 6.5 (1 H, d, CH5CHSO2, J 5mmol) in dry MeOH (5 ml), in a Pyrex reactor, was irradiated for
15.0 Hz); 6.7 (1 H, dd, CH5CHSO2, J 5 15.0 Hz, J 5 4.7 Hz);100 h at 354 nm with a 125-W Hg lamp, under shaking. The solvent
7.0 (2 H, broad, CONH2). 2 C12H23N3O5S (321.4): calcd. C 44.85,was collected and the resin was washed with MeOH (5 3 2 ml).
H 7.21, N 13.07, O 24.89, S 9.98; found C 44.80, H 7.28, N13.00.The combined organic fractions were concentrated at reduced
pressure. The residue was purified by flash chromatography (n-hex-
(S)-Boc-vsAla-N(Me)-(S)-vsVal-OEt (20, R 5 Me, R2 5 Me,
ane/ethyl acetate, 6:4) to give the desired product in 77% yield. The
R3 5 iPr): According to the above procedure, the desired product
spectra are identical to those reported for the compound synthe-
was obtained in 100% yield after purification by flash chromatog-
sized in solution.[11b]
raphy (n-hexane/ethyl acetate, 8:2). 2 1H NMR (200 MHz,
(S)-Boc-vsVal-(S)-vsAla-NH2 (16, R 5 Me, R1 5 iPr). Accord- CDCl3): ä 5 0.96 (3 H, d, CH3CHC, J 5 6.5 Hz); 1.03 (3 H, d,
ing to the above procedure with the (S)-Boc-vsVal-(S)-vsAla-linker- CH3CHC, J 5 6.5 Hz); 1.3 (3 H, d, CH3CHN, J 5 7.0 Hz); 1.42
B-NH-TentaGel resin (14, vsAA1 5 vsAla, vsAA2 5 vsVal) (200 (3 H, t, CH3CH2OSO2, J 5 7.2 Hz); 1.45 (9 H, s, [CH3]3C); 1.8 (1
mg, 0.046 mmol), a crude compound was obtained which was puri- H, m, Me2CHC); 2.7 (3 H, s, N-CH3); 4.1 (1 H, m, Me2CHCHN);
fied by flash chromatography (n-hexane/ethyl acetate, 7:3) to give 4.2 (2 H, q, CH3CH2OSO2, J 5 7.2 Hz); 4.4 (1 H, m, CH3CHN);
the desired product in 86% yield. The spectra are identical to those 4.7 (1 H, m, NH); 6.1 (1 H, dd, CH5CHSO2N, J 5 15 .0 Hz, J 5
reported for the compound synthesized in solution.[11b] 1.5 Hz); 6.45 (1 H, d, CH5CHSO3Et, J 5 15.0 Hz); 6.67 (1 H, dd,
CH5CHSO2N, J 5 15.0 Hz, J 5 4.8 Hz); 6.81 (1 H, dd, CH5N-Alkylation of vs-Peptides in Solution
CHSO2N, J 5 15.0 Hz, J 5 8.2 Hz). 2 C18H34N2O7S2 (454.6):
(S)-Boc-vsAla-NHMe (18, R 5 Me, R1 5 H, R2 5 Me): A solu- calcd: C 47.56, H 7.54, N 6.16, O 24.64, S 14.11; found C 47.51,
tion of (S)-Boc-vsAla-NH2 (17, R 5 Me, R1 5 H) (10 mg, 0.04 H 7.61, N 6.11.
mmol) in THF (0.4 ml) at room temp., under nitrogen, was treated
with Cs2CO3 (39 mg, 0.12 mmol) and MeI (17 mg, 0.12 mmol). (S)-Boc-Ala-(S)-vsAla-N(Me)Bn (22, R 5 Me, R2 5 Me): Ac-
cording to the above procedure, the desired product was obtainedThe white suspension was stirred for 3 h then the solvent was eva-
porated at reduced pressure and the residue was purified by flash in 96% yield after purification by flash chromatography (n-hexane/
ethyl acetate, 4:6). 2 1H NMR (200 MHz, CDCl3): ä 5 1.3 (3 H,chromatography (n-hexane/ethyl acetate, 7:3) to give the desired
product in 40% yield. 2 1H NMR (200 MHz, CDCl3): ä 5 1.3 (3 d, CH3CH, J 5 7.4 Hz); 1.4 (3 H, d, CH3CH, J 5 6.5 Hz); 2.7 (3
H, s, NCH3); 4.1 (1 H, m, CHCO); 4.2 (2 H, s, NCH2Ph); 4.7 (1H, d, CH3CH, J 5 7.8 Hz); 1.4 (9 H, s, [CH3]3C); 2.7 (3 H, d,
CH3NH, J 5 7.0 Hz); 4.2 (1 H, broad, NHCH3); 4.4 (1 H, m, H, m, CH3CHCH5); 4.9 (1 H, broad, NHCHCO); 6.3 (1 H, d,
CH5CHSO2, J 5 15.2 Hz); 6.4 (1 H, d, NHCO, J 5 6.5 Hz); 6.7CHCH3); 4.6 (1 H, broad, NHCH); 6.2 (1 H, d, CH5CHSO2, J 5
15.2 Hz); 6.7 (1 H, dd, CH5CHSO2, J 5 4.8 Hz, J 5 15.2 Hz). 2 (1 H, dd, CH5CHSO2, J 5 15.2 Hz, J 5 4.3 Hz); 7.3 (5 H, s, Ph-
H). 2 C20H31N3O5S (425.6): calcd: C 56.45, H 7.34, N 9.87, OC10H20N2O4S (264.3): calcd. C 45.44, H 7.63, N 10.60, O 24.21, S
12.13; found C 45.40, H 7.70, N 10.52. 18.80, S 7.53; found C 56.39, H 7.41, N 9.80.
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(S)-Boc-vsVal-N(Et)Bn (18, R 5 iPr, R1 5 Bn, R2 5 Et). A Solid Phase N-Alkylation of vs-Peptides
solution of (S)-Boc-vsVal-NHBn (17, R 5 iPr, R1 5 Bn) (14.7 mg,
(S)-Boc-vsAla-NHCH3 (23): The resin (S)-Boc-vsAla-linker-B-0.04 mmol) in THF (0.4 ml) at room temp., under nitrogen, was
NH-TentaGel (13, vsAA1 5 vsAla) (109 mg, 0.025 mmol) in DMFtreated with Cs2CO3 (39 mg, 0.12 mmol) and ethyl iodide (EtI) (19
(2 ml) was treated with Cs2CO3 (24.4 mg, 0.075 mmol) and MeImg, 0.12 mmol). The white suspension was stirred for 3 h, the sol-
(17.7 mg, 0.125 mmol). The mixture was shaken for 20 h andvent was evaporated at reduced pressure and the residue was puri-
washed with DMF (5 3 2 ml), MeOH (3 3 2 ml) and DCM (5 3fied by flash chromatography (n-hexane/ethyl acetate, 8:2) to give
2 ml). The resin was then suspended in dry MeOH (2 ml) andthe desired product in 100% yield. 2 1H NMR (200 MHz, CDCl3):
irradiated at 354 nm with a 125 Watt mercury lamp (Pyrex reactor)ä 5 0.89 (3 H, d, CH3CHCH3, J 5 6.6 Hz); 0.91 (3 H, d,
for 40 h, under shaking. The solvent was collected and the resinCH3CHCH3, J 5 6.6 Hz); 1.1 (3 H, t, CH3CH2, J 5 7.1 Hz); 1.44
was washed with MeOH (5 3 2 ml). The combined organic frac-(9 H, s, [CH3]3C); 1.85 [1 H, m, (CH3)2CH]; 3.25 (2 H, q,
tions were evaporated at reduced pressure to give a residue whichCH3CH2N, J 5 7.1 Hz); 4.15 (1 H, m, NHCH); 4.3 (2 H, s,
was purified by flash chromatography (n-hexane/ethyl acetate, 6:4)NCH2Ph); 4.55 (1 H, broad, NH); 6.25 (1 H, dd, CH5CHSO2,
to give the desired compound (23) in 50% yield. The spectra areJ 5 1.2 Hz, J 5 14.9 Hz); 6.65 (1 H, dd, CH5CHSO2, J 5 5.5
identical to those reported for the compound synthesized in solu-Hz, J 5 14.9 Hz); 7.4 (5 H, m, ArH). 2 C20H32N2O4S (396.6):
tion. [11b]calcd. C 60.58, H 8.13, N 7.06, O 16.14, S 8.09; found C 60.51, H
8.21, N 7.01. Synthesis of a Library of 357 Di-N-alkylated vs-Dipeptides 26
(S)-Boc-vsVal-NBn2 (18, R 5 iPr, R1 5 R2 5 Bn): A solution The resin Fmoc-linker-B-NH-TentaGel (9, 2.8 g, 0.56 mmol) was
of (S)-Boc-vsVal-NHBn (17, R 5 iPr, R1 5 Bn) (14.7 mg, 0.04 split into 7 pools (400 mg, 0.08 mmol). Each pool was treated with
mmol) in THF (0.4 ml) at room temp., under nitrogen, was treated 20% piperidine in DMF (2 3 4 ml) and then washed with DMF
with Cs2CO3 (39 mg, 0.12 mmol) and benzyl bromide (BnBr) (20.5 (3 3 4 ml) and DCM (5 3 4 ml). In the first library step, each
mg, 0.12 mmol). The white suspension was stirred for 3 h, the sol- pool (11), suspended in 4 ml of DCM, was treated with DMAP
vent was evaporated at reduced pressure and the residue was puri- (4.9 mg, 0.04 mmol), NMM (8.1 mg, 0.08 mmol) and the sulfonyl
fied by flash chromatography (n-hexane/ethyl acetate, 85:15) to give chloride, Boc-vsAA1-Cl, [0.16 mmol; (S)-Boc-vsAla-Cl (2a) 43.0
the desired product in 100% yield. 2 1H NMR (200 MHz, CDCl3): mg, (S)-Boc-vsVal-Cl (2b) 47.6 mg, (S)-Boc-vsLeu-Cl (2c) 49.9 mg,
ä 5 0.90 (3 H, d, CH3CHCH3, J 5 6.5 Hz); 0.92 (3 H, d, (S)-Boc-vsPhe-Cl (2d) 55.3 mg, (R)-Boc-vsPhe-Cl (2e) 55.3 mg, (S)-
CH3CHCH3, J 5 6.5 Hz); 1.47 (9 H, s, [CH3]3C); 1.83 [1 H, m, Boc-vsPro-Cl (2f) 47.3 mg, and (R)-Boc-vsPro-Cl (2g) 47.3 mg].
(CH3)2CH]; 4.15 (1 H, m, NHCH); 4.27 (4 H, s, 2 3 NCH2Ph); The mixtures were shaken for 18 h and the coupling cycle was
4.4 (1 H, broad, NH); 6.1 (1 H, dd, CH5CHSO2, J 5 1.2 Hz, J 5 repeated 3 times. At the end of each coupling cycle the resin was
15.0 Hz); 6.6 (1 H, dd, CH5CHSO2, J 5 5.3 Hz, J 5 15.0 Hz); washed with DCM (3 3 4 ml), MeOH (3 3 4 ml) and DCM (5 3
7.3 (10 H, m, 2 3 ArH). 2 C25H34N2O4S (458.6): calcd: C 65.47, 4 ml) and checked with the BPB test. [18] [21]
H 7.47, N 6.11, O 13.95, S 6.99; found C 65.38, H 7.54, N 6.05.
At the end of the third coupling cycle, a solution of acetic anhy-
(S)-Boc-vsAla-NHAll (18, R 5 Me, R1 5 H, R2 5 All): A solu- dride (0.40 ml) in DCM (4.0 ml) was added. The mixtures were
tion of (S)-Boc-vsAla-NH2 (17, R 5 Me, R1 5 H) (20 mg, 0.08 shaken for 19 h and then washed with DCM (5 3 4 ml), DMF (3
mmol) in THF (0.8 ml) at room temp., under nitrogen, was treated 3 4 ml) and DCM (3 3 4 ml). At the end of the first library step
with Cs2CO3 (78 mg, 0.24 mmol) and allyl bromide (AllBr) (29 mg, the pools were dried under vacuum and 100 mg of resin were drawn
0.24 mmol). The white suspension was stirred for 3 h, the solvent from each pool for the deconvolution. All the 7 pools were mixed
was evaporated at reduced pressure and the residue was purified by together in the same flask with DCM (30 ml), dried under vacuum
flash chromatography (n-hexane/ethyl acetate, 7:3) to give the de- and split into 3 pools.
sired product in 40% yield. 2 1H NMR (200 MHz, CDCl3): ä 5
In the second library step, each pool (13, 700 mg, 0.14 mmol)1.3 (3 H, d, CH3CH, J 5 6.9 Hz); 1.45 (9 H, s, [CH3]3C); 3.66 (2
suspended in 7 ml of DMF, was treated with Cs2CO3 (136.8 mg,H, m, NHCH2CH, J 5 6.0 Hz); 4.4 (2 H, broad, CH3CH 1
0.42 mmol) and the alkylating agent (0.7 mmol; AllBr 84.7 mg,NHSO2); 4.6 (1 H, d, NHCH, J 5 7.9 Hz); 5.2 (2 H, m, CH5
MeI 99.3 mg, BnBr 119.7 mg). The mixtures were shaken for 6 hCH2); 5.85 (1 H, m, CH2CH5CH2); 6.3 (1 H, dd, CH5CHSO2,
and the alkylating cycle was repeated 4 times. At the end of eachJ 5 15.0 Hz, J 5 1.4 Hz); 6.7 (1 H, dd, CH5CHSO2, J 5 4.9 Hz,
cycle the resin was washed with DMF (5 3 7 ml) and at the endJ 5 15.0 Hz). 2 C12H22N2O4S (290.4): calcd. C 49.64, H 7.64, N
of the last cycle the resin was washed with DMF (5 3 7 ml), MeOH9.65, O 22.04, S 11.04; found C 49.58, H 7.71, N 9.60.
(3 3 7 ml) and DMF (3 3 7 ml). The pools were then dried under
(S)-Boc-vsAla-NHCH2Napht (18, R 5 Me, R1 5 H, R2 5 vacuum and 200 mg of resin were drawn from each pool for the
NaphtCH2): A solution of (S)-Boc-vsAla-NH2 (17, R 5 Me, R1 5 deconvolution. All the 3 pools (24) were mixed together in the same
H) (10 mg, 0.04 mmol) in THF (0.4 ml) at room temp., under flask then treated with 25% TFA in DCM (3 3 15 ml), washed
nitrogen, was treated with Cs2CO3 (39 mg, 0.12 mmol) and 2- with DCM (5 3 15 ml), neutralized with 5% DIPEA in DCM (3
(bromomethyl)naphtalene (NaphtCH2-Br) (26 mg, 0.12 mmol). 3 15 ml) and finally washed again with DCM (5 3 15 ml). The
The white suspension was stirred for 3 h, the solvent was evapo- resin was dried under vacuum and split into 7 pools.
rated at reduced pressure and the residue was purified by flash
chromatography (n-hexane/ethyl acetate, 7:3) to give the desired In the third library step, each pool (215 mg, 0.04 mmol), sus-
pended in 2 ml of DCM, was treated with NMM (4 mg, 0.04product in 40% yield. 2 1H NMR (200 MHz, CDCl3): ä 5 1.2 (3
H, d, CH3CH, J 5 6.4 Hz); 1.45 (9 H, s, [CH3]3C); 4.4 (4 H, broad, mmol), DMAP (2.4 mg, 0.02 mmol) and the sulfonyl chloride, Boc-
vsAA2-Cl, [0.08 mmol; (S)-Boc-vsAla-Cl (2a) 22 mg, (S)-Boc-CHNH 1 CHNH 1 CH2Naph); 4.6 (1 H, broad, SO2NH); 6.2 (1
H, d, CH5CHSO2, J 5 14.3 Hz); 6.7 (1 H, dd, CH5CHSO2, J 5 vsVal-Cl (2b) 24 mg, (S)-Boc-vsLeu-Cl (2c) 25 mg, (S)-Boc-vsPheCl
(2d) 28 mg, (R)-Boc-vsPheCl (2e) 28 mg, (S)-Boc-vsProCl (2f) 2414.3 Hz, J 5 4.6 Hz); 7.427.9 (7 H, m, Naph-H). 2 C20H26N2O4S
(390.5): calcd. C 61.52, H 6.71, N 7.17, O 16.39, S 8.21; found C mg, and (R)-Boc-vsProCl (2g) 24 mg]. The mixtures were shaken
for 16 h and the coupling cycle was repeated 3 times. At the end61.45, H 6.77, N 7.12.
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of each cycle the resin was washed with DCM (3 3 2 ml), MeOH (3 with DCM (3 3 15 ml). The resin was dried under vacuum and
split into 9 pools.3 2 ml) and DCM (5 3 2 ml) and checked with the BPB test. [18] [21]
After the third coupling cycle, a solution of acetic anhydride In the second library step, each pool (170 mg, 0.034 mmol) sus-
(0.30 ml) in DCM (2.0 ml) was added. The mixtures were shaken pended in 2 ml of DCM, was treated with DMAP (2.1 mg, 0.017
for 19 h and then washed with DCM (5 3 2 ml), DMF (3 3 2 ml) mmol), NMM (3.44 mg, 0.034 mmol) and the sulfonyl chloride,
and DCM (3 3 2 ml). At the end of the third library step the pools Boc-vsAA2-Cl, [0.068 mmol; (S)-Boc-vsAla-Cl (2a) 18.3 mg, (S)-
were dried under vacuum and 100 mg of resin were drawn from Boc-vsVal-Cl (2b) 20.2 mg, (S)-Boc-vsLeu-Cl (2c) 21.2 mg, (S)-
each pool for the deconvolution. Boc-vsPhe-Cl (2d) 23.5 mg, (R)-Boc-vsPhe-Cl (2e) 23.5 mg, (S)-
Boc-vsPro-Cl (2f) 20.1 mg, (R)-Boc-vsPro-Cl (2g) 20.1 mg, (S)-The 7 pools (25) were mixed to form three new pools: the pool
Boc-vsSer(TBDPS)-Cl (2h) 35.6 mg, (S)-Boc-vsTyr(TBDPS)-Cl (2i)A-V (42 N-monoalkylated vs-dipeptides), obtained mixing pools A
40.8 mg]. The mixtures were shaken for 20 h and the coupling cycle[21 N-monoalkylated vs-dipeptides where the last vs-amino acid
was repeated twice. At the end of each cycle the resin was washedadded is (S)-vsAla] and V [21 N-monoalkylated vs-dipeptides
with DCM (3 3 2 ml), MeOH (3 3 2 ml) and DCM (5 3 2 ml)where the last vs-amino acid added is (S)-vsVal]; the pool L-F-P
and checked with the BPB test. [18] [21](63 N-monoalkylated vs-dipeptides), obtained mixing pools L [21
N-monoalkylated vs-dipeptides where the last vs-amino acid added After the coupling cycles, a solution of acetic anhydride (0.17
is (S)-vsLeu], F [21 N-monoalkylated vs-dipeptides where the last ml) in DCM (2.0 ml) was added. The mixtures were shaken for 4.5
vs-amino acid added is (S)-vsPhe] and P [21 N-monoalkylated vs- h and then washed with DCM (5 3 2 ml), DMF (3 3 2 ml) and
dipeptides where the last vs-amino acid added is (S)-vsPro]; the DCM (3 3 2 ml). At the end of the second library step the pools
pool f-p (42 N-monoalkylated vs-dipeptides), obtained mixing were dried under vacuum and 100 mg of resin were drawn from
pools f [21 N-monoalkylated vs-dipeptides where the last vs-amino each pool for the deconvolution. The 9 pools (28) were mixed to-
acid added is (R)-vsPhe] and p [21 N-monoalkylated vs-dipeptides gether in the same flask then treated with saturated HCl in ethyl
where the last vs-amino acid added is (R)-vsPro]. Each of these acetate (3 3 6.5 ml, 3 3 1 h), washed with DCM (3 3 6.5 ml),
three pools was split into three subpools for the fourth library step. neutralized with DIPEA 5% in DCM (3 3 6.5 ml), and finally
washed again with DCM (3 3 6.5 ml). The resin was dried underEach subpool A-V and f-p (80 mg, 0.016 mmol), suspended in 1
vacuum and split into 9 pools.ml of DMF, was treated with Cs2CO3 (15.6 mg, 0.048 mmol) and
the alkylating agent (0.08 mmol; AllBr 9.7 mg, MeI 11.3 mg, BnBr In the third library step, each pool (70 mg, 0.014 mmol), sus-
13.7 mg). Each subpool L-F-P (115 mg, 0.023 mmol), suspended pended in 1 ml of DCM, was treated with DMAP (1 mg, 0.007
in 1 ml of DMF, was treated with Cs2CO3 (22.8 mg, 0.07 mmol) mmol), NMM (1.4 mg, 0.014 mmol) and the sulfonyl chloride, Boc-
and the alkylating agent (0.115 mmol; AllBr 13.9 mg, MeI 16.3 mg, vsAA3-Cl, [0.028 mmol; (S)-Boc-vsAla-Cl (2a) 7.5 mg, (S)-Boc-
BnBr 19.7 mg). The mixtures were shaken for 6 h and the alkylating vsVal-Cl (2b) 8.3 mg, (S)-Boc-vsLeu-Cl (2c) 8.7 mg, (S)-Boc-vsPhe-
cycle was repeated 4 times. At the end of each cycle the resin was Cl (2d) 9.7 mg, (R)-Boc-vsPhe-Cl (2e) 9.7 mg, (S)-Boc-vsPro-Cl
washed with DMF (5 3 1 ml) and at the end of the last cycle the (2f) 8.2 mg, (R)-Boc-vsPro-Cl (2g) 8.2 mg, (S)-Boc-vsSer(TBDPS)-
resin was washed with DMF (5 3 1 ml), MeOH (3 3 1 ml) and Cl (2h) 14.7 mg, (S)-Boc-vsTyr(TBDPS)-Cl (2i) 16.8 mg]. The mix-
DMF (3 3 1 ml). At the end of the fourth library step the subpools tures were shaken for 20 h and the coupling cycle was repeated
(26) were dried under vacuum and the library was used for the twice. At the end of each cycle the resin was washed with DCM (3
biological assays. 3 1 ml), MeOH (3 3 1 ml) and DCM (5 3 1 ml) and checked
with the BPB test. [18] [21]Synthesis of a Library of 729 Functionalized vs-Tripeptides 29
After the coupling cycles, a solution of acetic anhydride (0.07The resin Fmoc-linker-B-NH-TentaGel (9, 2.45 g, 0.49 mmol)
ml) in DCM (1.0 ml) was added. The mixtures were shaken for 4.5was split into 9 pools (270 mg, 0.054 mmol). Each pool was treated
h and then washed with DCM (5 3 1 ml), DMF (3 3 1 ml) andwith 20% piperidine in DMF (2 3 3 ml) and then washed with
DCM (3 3 1 ml).DMF (3 3 3 ml) and DCM (5 3 3 ml). In the first library step,
each pool (11) suspended in 3 ml of DCM, was treated with DMAP At the end of the third library step the TBDPS protecting groups
(3.3 mg, 0.027 mmol), NMM (5.46 mg, 0.054 mmol) and the sul- were removed by treatment with TBAF (1 M in THF, 0.14 ml, 0.14
fonyl chloride, Boc-vsAA1-Cl, [0.108 mmol; (S)-Boc-vsAla-Cl (2a) mmol) in THF (3 3 0.86 ml, 3 3 1 h). At the end of each cycle
29.1 mg, (S)-Boc-vsVal-Cl (2b) 32.2 mg, (S)-Boc-vsLeu-Cl (2c) 33.7 the resin was washed with THF (3 3 1 ml) and at the end of the
mg, (S)-Boc-vsPhe-Cl (2d) 37.3 mg, (R)-Boc-vsPhe-Cl (2e) 37.3 last cycle the resin was washed with THF (1 ml), AcOH 1% in
mg, (S)-Boc-vsPro-Cl (2f) 32.0 mg, (R)-Boc-vsPro-Cl (2g) 32.0 mg, THF (1 ml), THF (3 3 1 ml), MeOH (3 3 1 ml) and DCM (5 3
(S)-Boc-vsSer(TBDPS)-Cl (2h) 56.6 mg, (S)-Boc-vsTyr(TBDPS)-Cl 1 ml). The pools (29) were finally dried under vacuum and the
(2i) 64.8 mg]. The mixtures were shaken for 18 h and the coupling library was used for the biological assays.
cycle was repeated twice. At the end of each cycle the resin was
Synthesis of a Library of 625 vs-Tetrapeptides 33
washed with DCM (3 3 3 ml), MeOH (3 3 3 ml) and DCM (5 3
The resin Boc-linker-A-NH-TentaGel (8, 1 g, 0.2 mmol) was split3 ml) and checked with the BPB test. [18] [21]
into 5 pools (200 mg, 0.04 mmol). Each pool was treated with 25%
After the coupling cycles, a solution of acetic anhydride (0.27
TFA in DCM (3 3 10 ml), washed with DCM (5 3 10 ml), neu-
ml) in DCM (3.0 ml) was added. The mixtures were shaken for 4.5
tralized with 10% TEA in DCM (3 3 10 ml) and then washed with
h and then washed with DCM (5 3 3 ml), DMF (3 3 3 ml) and
DCM (6 3 10 ml).
DCM (3 3 3 ml). At the end of the first library step the pools were
dried under vacuum and 100 mg of resin were drawn from each In the first library step, each pool (10), suspended in 5 ml of
DCM, was treated with DMAP (4.9 mg, 0.04 mmol), DBU (6.1pool for the deconvolution. The 9 pools (27) were mixed together
in the same flask then treated with saturated HCl in ethyl acetate mg, 0.04 mmol) and the sulfonyl chloride, (S)-Boc-vsAA1-Cl, [0.08
mmol; (S)-Boc-vsAla-Cl (2a) 21.6 mg, (S)-Boc-vsVal-Cl (2b) 23.8(3 3 15 ml, 3 3 1 h), washed with DCM (3 3 15 ml), neutralized
with DIPEA 5% in DCM (3 3 15 ml), and finally washed again mg, (S)-Boc-vsLeu-Cl (2c) 24.9 mg, (S)-Boc-vsPhe-Cl (2d) 27.7 mg,
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(S)-Boc-vsPro-Cl (2f) 23.6 mg]. The mixtures were shaken for 4 h the fourth library step the pools (33) were dried under vacuum and
the library was used for the biological assays.and the coupling cycle was repeated 4 times. At the end of each
cycle the resin was washed with DCM (3 3 5 ml), MeOH (3 3 5 Michael Addition Reactions
ml) and DCM (5 3 5 ml) and checked with the BPB test. [18] [21]
Pyrrolidinone (35; R 5 Me; R1, R1 5 2(CH2)52; R2 5 CO2Me):
At the end of the first library step the pools were dried under Dimethyl malonate (16.6 mg, 0.126 mmol) was added dropwise to
vacuum and 50 mg of resin was drawn from each pool for the a suspension of NaH (60% oil dispersion, 5 mg, 0.126 mmol) in
deconvolution. The 5 pools (30) were mixed together in the same dry THF (0.32 ml) under nitrogen, at room temperature. After
flask then treated with 25% TFA in DCM (3 3 10 ml), washed some minutes a solution of (S)-Boc-vsAla-N[2(CH2)5-] [34; R 5
with DCM (5 3 10 ml), neutralized with 10% TEA in DCM (3 3 Me; R1, R1 5 2(CH2)5-] (20 mg, 0.063 mmol) in dry THF (0.21
10 ml) and finally washed again with DCM (5 3 10 ml). The resin ml) was added by cannula. The mixture was stirred at 60°C for 16
was dried under vacuum and split into 5 pools. h, cooled to room temperature and pH 5 7 phosphate buffer (1
ml) was added. The aqueous phase was extracted with DCM andIn the second library step, each pool (150 mg, 0.03 mmol), sus-
the combined organic extracts were dried and concentrated. Thepended in 5 ml of DCM, was treated with DMAP (4 mg, 0.03
crude product was purified by flash chromatography (n-hexane/mmol), DBU (4.6 mg, 0.03 mmol) and the sulfonyl chloride, (S)-
ethyl acetate, 65:35) to give a mixture of two diastereoisomers (34%Boc-vsAA2-Cl, [0.06 mmol; (S)-Boc-vsAla-Cl (2a) 16 mg, (S)-Boc-
overall yield) in the ratio of 85:15. 2 1H NMR (300 MHz, CDCl3):vsVal-Cl (2b) 17.9 mg, (S)-Boc-vsLeu-Cl (2c) 18.7 mg, (S)-Boc-
ä 5 1.3 (3 H, d, CH3CH, J 5 6.5 Hz); 1.5 (9 H, s, [CH3]3C); 1.7vsPhe-Cl (2d) 20.7 mg, (S)-Boc-vsPro-Cl (2f) 17.7 mg]. The mix-
[6 H, m, NCH2(CH2)3); 3.05 (3 H, m, CH 1 CH2SO2); 3.3 (5 H,tures were shaken for 4 h and the coupling cycle was repeated 5
m, CH2NCH2 1 CH); 3.8 (3 H, s, OCH3); 4.1 (1 H, m, CH3CH,times for (S)-Boc-vsAla-Cl (2a), (S)-Boc-vsLeu-Cl (2c) and (S)-
15%); 4.6 (1 H, m, CH3CH, 85%). 2 13C NMR (CDCl3): ä 5Boc-vsPro-Cl (2f) and 7 times for (S)-Boc-vsVal-Cl (2b) and (S)-
14.48 (CH3); 23.57 (N(CH2)2CH2); 25.52 (2 3 NCH2CH2); 27.87Boc-vsPhe-Cl (2d). At the end of each cycle the resin was washed
([CH3]3C); 34.81 (CHCH2SO2); 46.56 (CH2NCH2); 52.69with DCM (3 3 5 ml), MeOH (3 3 5 ml) and DCM (5 3 5 ml)
(CH3CH); 54.04 (CHCOO); 83.76 ([CH3]3C); 145.30 (OC(5O)N);and checked with the BPB test. [18] [21]
166.09 (COOCH3); 167.70 (NC5O). 2 C18H30N2O7S (418.5):At the end of the second library step the pools were dried under calcd. C 51.66, H 7.23, N 6.69, O 26.76, S 7.66; found C 51.60, H
vacuum and 50 mg of resin were drawn from each pool for the 7.30, N 6.65.
deconvolution. The 5 pools (31) were mixed together in the same
flask then treated with 25% TFA in DCM (3 3 10 ml), washed Figure 3. Major diastereomer obtained from the addition of so-
dium dimethyl malonate to (S)-Boc-vsAla-N[2(CH2)52] [34; R 5with DCM (5 3 10 ml), neutralized with 10% TEA in DCM (3 3
Me; R1, R1 5 2(CH2)52]10 ml) and finally washed again with DCM (5 3 10 ml). The resin
was dried under vacuum and split into 5 pools.
In the third library step, each pool (100 mg, 0.02 mmol), sus-
pended in 5 ml of DCM, was treated with DMAP (2.4 mg, 0.02
mmol), DBU (3 mg, 0.02 mmol) and the sulfonyl chloride, (S)-Boc-
vsAA3-Cl, [0.04 mmol; (S)-Boc-vsAla-Cl (2a) 10.8 mg, (S)-Boc-
vsVal-Cl (2b) 11.9 mg, (S)-Boc-vsLeu-Cl (2c) 12.5 mg, (S)-Boc-
vsPhe-Cl (2d) 13.8 mg, (S)-Boc-vsPro-Cl (2f) 11.8 mg]. The mix-
tures were shaken for 4 h and the coupling cycle was repeated 7
times for (S)-Boc-vsAla-Cl (2a) and (S)-Boc-vsLeu-Cl (2c) and 14 Table 1. NOE effects observed in structure 36 (s 5 small effect,
m 5 medium effect, h 5 high effect, n 5 no effect)times for (S)-Boc-vsVal-Cl (2b), (S)-Boc-vsPhe-Cl (2d) and (S)-
Boc-vsPro-Cl (2f). At the end of each cycle the resin was washed
5-H 4-H 3-H 5-CH3 4-CH2with DCM (3 3 5 ml), MeOH (3 3 5 ml) and DCM (5 3 5 ml)
and checked with the BPB test. [18] [21]
5-H 2 s n h n
At the end of the third library step the pools were dried under 4-H s 2 n n s
vacuum and 50 mg of resin were drawn from each pool for the 3-H n n 2 s m
5-CH3 h n s 2 hdeconvolution. The 5 pools (32) were mixed together in the same
4-CH2 n s m h 2flask then treated with 25% TFA in DCM (3 3 10 ml), washed
with DCM (5 3 10 ml), neutralized with 10% TEA in DCM (3 3
10 ml) and finally washed again with DCM (5 3 10 ml). The resin
Pyrrolidinone (35; R 5 iPr; R1 5 Me; R2 5 CO2Me): Accordingwas dried under vacuum and split into 5 pools.
to the above procedure, the product was obtained as a single dia-
stereomer in 56% yield after purification by flash chromatographyIn the fourth library step, each pool (23 mg, 0.006 mmol), sus-
pended in 2.5 ml of DCM, was treated with DMAP (0.7 mg, 0.006 (n-hexane/ethyl acetate, 6:4). 2 1H NMR (300 MHz, CDCl3): ä 5
0.90 (3 H, d, CH3CH, J 5 7.4 Hz); 1.10 (3 H, d, CH3CH, J 5 7.4mmol), DBU (0.91 mg, 0.006 mmol) and the sulfonyl chloride, (S)-
Boc-vsAA4-Cl, [0.012 mmol; (S)-Boc-vsAla-Cl (2a) 3.2 mg, (S)- Hz); 1.50 (9 H, s, [CH3]3C); 2.20 [1 H, m, (CH3)2CH]; 2.9 [6 H, s,
(CH3)2N]; 3.05 (1 H, dd, CHHSO2, J 5 5.0 Hz, J 5 14.0 Hz); 3.15Boc-vsVal-Cl (2b) 3.6 mg, (S)-Boc-vsLeu-Cl (2c) 3.7 mg, (S)-Boc-
vsPhe-Cl (2d) 4.1 mg, (S)-Boc-vsPro-Cl (2f) 3.5 mg]. The mixtures (1 H, dd ,CHHSO2, J 5 8.0 Hz, J 5 14.0 Hz); 3.40 (1 H, m,
CHCH2); 3.50 (1 H, d, CHCO, J 5 12.0 Hz); 3.8 (3 H, s, CH3O);were shaken for 4 h and the coupling cycle was repeated 11 times
for (S)-Boc-vsAla-Cl (2a) and (S)-Boc-vsLeu-Cl (2c), 22 times for 4.5 (1 H, m, NCH). 2 13C NMR (CDCl3): ä 5 17.39 (CH3CH);
22.09 (CH3CH); 27.94 ([CH3]3C); 29.56 (CH); 37.42 ([(CH3)2]N);(S)-Boc-vsPhe-Cl (2d) and (S)-Boc-vsPro-Cl (2f) and 32 times for
(S)-Boc-vsVal-Cl (2b). At the end of each cycle the resin was 47.10 (CH2); 53.26 (OCH3); 54.13 (CH); 61.29 (CH). 2
C17H30N2O7S (406.5): calcd. C 50.23, H 7.44, N 6.89, O 27.55, Swashed with DCM (3 3 2.5 ml), MeOH (3 3 2.5 ml) and DCM
(5 3 2.5 ml) and checked with the BPB test. [18] [21] At the end of 7.89; found C 50.17, H 7.51, N 6.85.
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hohl, C. von dem Bussche-Hünnefeld, A. Lansky, C. Zechel,Pyrrolidinone (35; R 5 Me; R1 5 Me; R2 5 CO2Me): According Angew. Chem. 1996, 108, 243622487, Angew. Chem. Int. Ed.to the above procedure, the product was obtained in 40% yield Engl. 1996, 35, 228822337. 2 [4c] L. A. Thompson, J. A. Ell-
after purification by flash chromatography (n-hexane/ethyl acetate, man, Chem. Rev. 1996, 96, 5552600. 2 [4d] K. S. Lam, M. Lebl,
V. Krchn˜a´k, Chem. Rev. 1997, 97, 4112448.6:4). 2 1H NMR (200 MHz, CDCl3): ä 5 1.3 (3 H, d, CH3CH,
[5] [5a] A. Giannis, T. Kolter, Angew. Chem. 1993, 105, 130321326;J 5 6.4 Hz); 1.5 (9 H, s, [CH3]3C); 2.9 [6 H, s, (CH3)2N]; 3.1 (2 H,
Angew. Chem. Int. Ed. Engl. 1993, 32, 124421267. 2 [5b] J.d, CH2SO2, J 5 6.5 Hz); 3.223.3 (1 H, m, CHCH2SO2); 3.4 (1 H, Gante, ibid. 1994, 106, 178021802 and 1994, 33, 169921720.
d, CHCO, J 5 12.5 Hz); 3.8 (3 H, s, CH3O); 4.5 (1 H, m, CH3CH). [6] For recent examples, see: [6a] D. P. Rotella, J. Am. Chem. Soc.
2 C15H26N2O7S (378.4): calcd: C 47.61, H 6.92, N 7.40, O 29.59, 1996, 118, 12246212247. 2 [6b] P. Wipf, T. C. Henninger, J. Org.
Chem. 1997, 62, 158621587, and references therein.S 8.47; found C 47.56, H 6.99, N 7.35.
[7] [7a] W. J. Moree, G. A. van der Marel, R. M. J. Liskamp, Tetra-
Pyrrolidinone (35; R 5 iBu; R1 5 Me; R2 5 CO2Me): According hedron Lett. 1991, 32, 4092412. 2 [7b] W. J. Moree, G. A. van
der Marel, R. M. J. Liskamp, Tetrahedron Lett. 1992, 33,to the above procedure, the product was obtained in 20% yield
638926392. 2 [7c] W. J. Moree, L. C. van Gent, G. A. van derafter purification by flash chromatography (n-hexane/ethyl acetate,
Marel, R. M. J. Liskamp, Tetrahedron 1993, 49, 113321150. 26:4). 2 1H NMR (200 MHz, CDCl3): ä 5 0.91 (3 H, d, CH3CH, [7d] W. J. Moree, A. Schouten, J. Kroon, R. M. J. Liskamp, Int.
J 5 7.3 Hz); 0.98 (3 H, d, CH3CH, J 5 7.3 Hz); 1.55 (9 H, s, J. Peptide Protein Res. 1995, 45, 5012507. 2 [7e] D. B. A. de
Bont, W. J. Moree, R. M. J. Liskamp, Bioorg. Med. Chem. 1996,[CH3]3C); 1.621.8 [3 H, m, (CH3)2CH 1 NCHCH2]; 2.9 (6 H, s,
4, 6672672. 2 [7f] D. W. P. M. Loewik, S. J. E. Mulders, Y.[(CH3)2]N); 3.023.2 (3 H, m, CHCH2SO2 1 CHCH2SO2); 3.6 (1 Cheng, Y. Shao, R. M. J. Liskamp, Tetrahedron Lett. 1996, 37,H, broad, CHCO); 3.8 (3 H, s, OCH3); 4.1 (1 H, m, NCH, J 5 6.6 825328256. 2 [7g] D. B. A. de Bont, G. D. H. Dijkstra, J. A. J.
Hz). 2 C18H32N2O7S (420.5): calcd. C 51.41, H 7.67, N 6.66, O den Hartog, R. M. J. Liskamp, Bioorg. Med. Chem. Lett. 1996,
6, 303523040. 2 [7h] G. Pagani Zecchini, M. Paglialunga Parad-26.63, S 7.62; found C 51.35, H 7.74, N 6.61.
isi, I. Torrini, G. Lucente, E. Gavuzzo, F. Mazza, G. Pochetti,
Pyrrolidinone (35; R 5 iPr; R1 5 Me; R2 5 CN): According to Tetrahedron Lett. 1991, 32, 677926782. 2 [7i] A. Calcagni, E.
Gavuzzo, F. Mazza, F. Pinnen, G. Pochetti, D. Rossi, Gazz.the above procedure, the product was obtained in 15% yield after
Chim. Ital. 1992, 122, 17223. 2 [7j] G. Luisi, A. Calcagni, F.purification by flash chromatography (n-hexane/ethyl acetate, 6:4).
Pinnen, Tetrahedron Lett. 1993, 34, 239122392. 2 [7k] A. Cal-
2 1H NMR (200 MHz, CDCl3): ä 5 0.90 (3 H, d, CH3CH, J 5 cagni, D. Rossi, M. Paglialunga Paradisi, G. Lucente, E. Ga-
6.4 Hz); 1.10 (3 H, d, CH3CH, J 5 6.4 Hz); 1.50 (9 H, s, [CH3]3C); vuzzo, F. Mazza, G. Pochetti, M. Paci, Biopolymers 1997, 41,
5552567.2.20 [1 H, m, (CH3)2CH]; 2.9 [6 H, s, (CH3)2N]; 3.223.3 (3 H, m,
[8] [ 8a] C. H. Levenson, R. B. Meyer Jr, J. Med. Chem. 1984, 27,CHCH2 1 CHCH2); 3.6 (1 H, d, CHCN, J 5 12.5 Hz); 4.6 (1
2282232. 2 [8b] R. Gue´gan, J. Diaz, C. Cazaubon, M. Beau-H, m, NCH). 2 13C NMR (CDCl3): ä 5 17.40 (CH3CH); 22.00 mont, C. Carlet, J. Cle´ment, H. Demarne, M. Mellet, J. P.
(CH3CH); 28.00 ([CH3]3C); 29.00 (CH); 37.40 [(CH3)2N]; 46.00 Richaud, D. Segondy, M. Vedel, J. P. Gagnol, R. Roncucci, B.
(CH2); 61.40 (CH); 85.00 ([CH3]3C); 114.80 (CN). 2 C16H27N3O5S Castro, P. Corvol, G. Evin, B. P. Roques, J. Med. Chem. 1986,
29, 115221159. 2 [8c] H. Mazdiyasni, D. B. Konopacki, D. A.(373.5): calcd: C 51.46, H 7.29, N 11.25, O 21.42, S 8.59; found C
Dickman, T. M. Zydowsky, Tetrahedron Lett. 1993, 34,51.40, H 7.36, N 11.16. 4352438. 2 [8d] K. G. Carson, C. F. Schwender, H. N. Shroff,
N. A. Cochran, D. L. Gallant, M. J. Briskin, Bioorg. Med.
Chem. Lett. 1997, 7, 7112714.[1] [1a] M. A. Gallop, R. W. Barrett, W. J. Dower, S. P. A. Fodor, [9] M. Gude, U. Piarulli, D. Potenza, B. Salom, C. Gennari, Tetra-E. M. Gordon, J. Med. Chem. 1994, 37, 123321251. 2 [1b] E.
hedron Lett. 1996, 37, 858928592.M. Gordon, R. W. Barrett, W. J. Dower, S. P. A. Fodor, M. A. [10] vsAA-OH 5 vinylogous sulfonyl amino acid. Defined vinylog-Gallop, J. Med. Chem. 1994, 37, 138521401. 2 [1c] N. K. Ter-
ous sulfonyl amino acid residues are described by the vs prefixrett, M. Gardner, D. W. Gordon, R. J. Kobylecki, J. Steele,
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